Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by US Bancorp DE

US Bancorp DE boosted its position in Elanco Animal Health Incorporated (NYSE:ELAN) by 18.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,906 shares of the company’s stock after acquiring an additional 2,346 shares during the quarter. US Bancorp DE’s holdings in Elanco Animal Health were worth $157,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Allworth Financial LP lifted its stake in shares of Elanco Animal Health by 791.7% during the first quarter. Allworth Financial LP now owns 2,354 shares of the company’s stock worth $25,000 after purchasing an additional 2,090 shares in the last quarter. CoreCap Advisors LLC acquired a new position in shares of Elanco Animal Health in the fourth quarter worth about $29,000. NBC Securities Inc. acquired a new position in shares of Elanco Animal Health in the first quarter worth about $40,000. Parallel Advisors LLC lifted its stake in shares of Elanco Animal Health by 92.2% in the first quarter. Parallel Advisors LLC now owns 3,860 shares of the company’s stock worth $41,000 after acquiring an additional 1,852 shares in the last quarter. Finally, Versant Capital Management Inc lifted its stake in shares of Elanco Animal Health by 65.9% in the first quarter. Versant Capital Management Inc now owns 4,382 shares of the company’s stock worth $46,000 after acquiring an additional 1,740 shares in the last quarter. Institutional investors and hedge funds own 97.48% of the company’s stock.

Elanco Animal Health Stock Down 0.2%

Shares of Elanco Animal Health stock opened at $17.97 on Friday. The company has a current ratio of 2.60, a quick ratio of 1.40 and a debt-to-equity ratio of 0.61. The business’s 50 day simple moving average is $14.73 and its 200-day simple moving average is $12.27. The stock has a market capitalization of $8.93 billion, a price-to-earnings ratio of 20.90, a PEG ratio of 3.33 and a beta of 1.66. Elanco Animal Health Incorporated has a twelve month low of $8.02 and a twelve month high of $18.08.

Elanco Animal Health (NYSE:ELAN) last posted its earnings results on Thursday, August 7th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.20 by $0.06. Elanco Animal Health had a return on equity of 7.04% and a net margin of 9.68%. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same period last year, the firm earned $0.30 EPS. The firm’s revenue was up 4.8% compared to the same quarter last year. Equities research analysts forecast that Elanco Animal Health Incorporated will post 0.91 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. William Blair upgraded Elanco Animal Health from a “market perform” rating to an “outperform” rating in a research note on Thursday, June 26th. Leerink Partnrs upgraded Elanco Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 17th. Stifel Nicolaus upped their price objective on Elanco Animal Health from $16.00 to $17.00 and gave the company a “buy” rating in a research note on Wednesday, July 2nd. Wall Street Zen upgraded Elanco Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Finally, Piper Sandler increased their price target on Elanco Animal Health from $12.00 to $18.00 and gave the stock a “neutral” rating in a research report on Monday, August 11th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $17.33.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.